Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Retinal Vein Occlusion (CRVO)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01678248
What this trial is testing

The Effectiveness of Intravitreal Avastin Injection for CRVO

Who this might be right for
Central Retinal Vein Occlusion
Ziv Hospital 68
Post-approval studies (Phase 4)UnknownNCT01857544
What this trial is testing

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

Who this might be right for
Retinal Vein Occlusion
Tennessee Retina 10
Early research (Phase 1)Ended earlyNCT01225146
What this trial is testing

Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)

Who this might be right for
IschemiaRetinal Vein OcclusionPathologic Processes+2 more
David M. Brown, M.D. 8
Large-scale testing (Phase 3)Study completedNCT01396083
What this trial is testing

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Visual ImpairmentMacular EdemaCentral Retinal Vein Occlusion
Novartis Pharmaceuticals 243
Large-scale testing (Phase 3)Study completedNCT01976312
What this trial is testing

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 252
Large-scale testing (Phase 3)Study completedNCT00485836
What this trial is testing

The Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 392
Large-scale testing (Phase 3)Study completedNCT01012973
What this trial is testing

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Retinal Vein Occlusion
Bayer 177
Large-scale testing (Phase 3)Study completedNCT00567697
What this trial is testing

Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO

Who this might be right for
Central Retinal Vein OcclusionMacular Edema
Aleris Helse 32
Large-scale testing (Phase 3)Ended earlyNCT03810313
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion
Novartis Pharmaceuticals 493
Early research (Phase 1)Study completedNCT00406796
What this trial is testing

Lucentis for Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
California Retina Consultants 20
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Not applicableUnknownNCT02091505
What this trial is testing

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO

Who this might be right for
Central Retinal Vein Occlusion
Mie University 30
Large-scale testing (Phase 3)Study completedNCT00493064
What this trial is testing

To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions

Who this might be right for
Retinal Vein Occlusion
Palo Alto Medical Foundation 63
Large-scale testing (Phase 3)Study completedNCT01449682
What this trial is testing

Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.

Who this might be right for
Retinal Vein OcclusionMacular Edema
Retina Macula Institute 10
Large-scale testing (Phase 3)Study completedNCT00105027
What this trial is testing

The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

Who this might be right for
Macular Edema, CystoidRetinal Vein Occlusion
The Emmes Company, LLC 682
Post-approval studies (Phase 4)Study completedNCT01580020
What this trial is testing

Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO

Who this might be right for
Retinal Vein Occlusion
Novartis Pharmaceuticals 175
Not applicableStudy completedNCT02645747
What this trial is testing

Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Bayer 126
Not applicableUnknownNCT04601701
What this trial is testing

Central Retinal Vein Occlusion (CRVO) Treatment With Bevacizumab and Dexamethasone or Bevacizumab Only.

Who this might be right for
Central Retinal Vein Occlusion
He Eye Hospital 100
Early research (Phase 1)Study completedNCT00071227
What this trial is testing

Eye Injections of Triamcinolone Acetonide for Retinal Blood Vessel Disorders

Who this might be right for
Macular DegenerationRetinal Vein Occlusion
National Eye Institute (NEI) 16
Testing effectiveness (Phase 2)UnknownNCT02405741
What this trial is testing

Hyperbaric Chamber for Central Retinal Vein Occlusion (CRVO) Patients

Who this might be right for
Central Retinal Vein Occlusion
Assaf-Harofeh Medical Center 20
Next Page